Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy.
Morten Orebo HolmströmGuy W NovotnyJesper PetersenMia Aaboe-JørgensenHans Carl HasselbalchMads Hald AndersenSigne Ledou NielsenDaniel El FassiClaudia SchöllkopfPublished in: Leukemia & lymphoma (2019)
Keyphrases